Translational Mini-review Series on Complement Factor H: Structural and Functional Correlations for Factor H

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 2007 Dec 18

PMID 18081691

Citations 71

Authors

C Q Schmidt

A P Herbert

H G Hocking

D Uhrin

P N Barlow

Affiliations

Soon will be listed here.

Abstract

The 155-kDa glycoprotein, complement factor H (CFH), is a regulator of complement activation that is abundant in human plasma. Three-dimensional structures of over half the 20 complement control protein (CCP) modules in CFH have been solved in the context of single-, double- and triple-module segments. Proven binding sites for C3b occupy the N and C termini of this elongated molecule and may be brought together by a bend in CFH mediated by its central CCP modules. The C-terminal CCP 20 is key to the ability of the molecule to adhere to polyanionic markers on self-surfaces where CFH acts to regulate amplification of the alternative pathway of complement. The surface patch on CCP 20 that binds to model glycosaminoglycans has been mapped using nuclear magnetic resonance (NMR), as has a second glycosaminoglycan-binding patch on CCP 7. These patches include many of the residue positions at which sequence variations have been linked to three complement-mediated disorders: dense deposit disease, age-related macular degeneration and atypical haemolytic uraemic syndrome. In one plausible model, CCP 20 anchors CFH to self-surfaces via a C3b/polyanion composite binding site, CCP 7 acts as a 'proof-reader' to help discriminate self- from non-self patterns of sulphation, and CCPs 1-4 disrupt C3/C5 convertase formation and stability.

Citing Articles

Factor B as a therapeutic target for the treatment of complement-mediated diseases.

Kavanagh D, Barratt J, Schubart A, Webb N, Meier M, Fakhouri F Front Immunol. 2025; 16:1537974.

PMID: 40028332 PMC: 11868072. DOI: 10.3389/fimmu.2025.1537974.

Complement factor H in molecular regulation of angiogenesis.

Li J, Wang K, Starodubtseva M, Nadyrov E, Kapron C, Hoh J Med Rev (2021). 2024; 4(5):452-466.

PMID: 39444793 PMC: 11495524. DOI: 10.1515/mr-2023-0048.

PolySialic Acid Nanoparticles Actuate Complement-Factor-H-Mediated Inhibition of the Alternative Complement Pathway: A Safer Potential Therapy for Age-Related Macular Degeneration.

Peterson S, Krishnan A, Patel D, Khanehzar A, Lad A, Shaughnessy J Pharmaceuticals (Basel). 2024; 17(4).

PMID: 38675477 PMC: 11053938. DOI: 10.3390/ph17040517.

Gliosis-dependent expression of complement factor H truncated variants attenuates retinal neurodegeneration following ischemic injury.

Biber J, Jabri Y, Glanzer S, Dort A, Hoffelner P, Schmidt C J Neuroinflammation. 2024; 21(1):56.

PMID: 38388518 PMC: 10885619. DOI: 10.1186/s12974-024-03045-3.

Exploring the involvement of the alternative complement pathway in non-infectious uveitis pathogenesis.

Kulshrestha P, Goel P, Murthy S, Tyagi M, Basu S, Gogri P Front Immunol. 2024; 14:1222998.

PMID: 38187376 PMC: 10768558. DOI: 10.3389/fimmu.2023.1222998.

References

Klickstein L, Wong W, Smith J, Weis J, Wilson J, Fearon D . Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins. J Exp Med. 1987; 165(4):1095-112. PMC: 2188588. DOI: 10.1084/jem.165.4.1095. View

Manuelian T, Hellwage J, Meri S, Caprioli J, Noris M, Heinen S . Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J Clin Invest. 2003; 111(8):1181-90. PMC: 152934. DOI: 10.1172/JCI16651. View

Misasi R, Huemer H, Schwaeble W, Solder E, Larcher C, Dierich M . Human complement factor H: an additional gene product of 43 kDa isolated from human plasma shows cofactor activity for the cleavage of the third component of complement. Eur J Immunol. 1989; 19(9):1765-8. DOI: 10.1002/eji.1830190936. View

Ripoche J, Day A, Harris T, Sim R . The complete amino acid sequence of human complement factor H. Biochem J. 1988; 249(2):593-602. PMC: 1148743. DOI: 10.1042/bj2490593. View

Jokiranta T, Cheng Z, Seeberger H, Jozsi M, Heinen S, Noris M . Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site. Am J Pathol. 2005; 167(4):1173-81. PMC: 1603661. DOI: 10.1016/S0002-9440(10)61205-9. View

Kavanagh D, Goodship T, Richards A . Atypical haemolytic uraemic syndrome. Br Med Bull. 2006; 77-78:5-22. DOI: 10.1093/bmb/ldl004. View

Soares D, Gerloff D, Syme N, Coulson A, Parkinson J, Barlow P . Large-scale modelling as a route to multiple surface comparisons of the CCP module family. Protein Eng Des Sel. 2005; 18(8):379-88. DOI: 10.1093/protein/gzi039. View

Abrera-Abeleda M, Nishimura C, Smith J, Sethi S, McRae J, Murphy B . Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J Med Genet. 2005; 43(7):582-9. PMC: 2564553. DOI: 10.1136/jmg.2005.038315. View

Jokiranta T, Zipfel P, Hakulinen J, Kuhn S, Pangburn M, Tamerius J . Analysis of the recognition mechanism of the alternative pathway of complement by monoclonal anti-factor H antibodies: evidence for multiple interactions between H and surface bound C3b. FEBS Lett. 1996; 393(2-3):297-302. DOI: 10.1016/0014-5793(96)00905-2. View

10.

Norman D, Barlow P, Baron M, Day A, Sim R, Campbell I . Three-dimensional structure of a complement control protein module in solution. J Mol Biol. 1991; 219(4):717-25. DOI: 10.1016/0022-2836(91)90666-t. View

11.

Jokiranta T, Hellwage J, Koistinen V, Zipfel P, Meri S . Each of the three binding sites on complement factor H interacts with a distinct site on C3b. J Biol Chem. 2000; 275(36):27657-62. DOI: 10.1074/jbc.M002903200. View

12.

Kraiczy P, Hellwage J, Skerka C, Becker H, Kirschfink M, Simon M . Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins. J Biol Chem. 2003; 279(4):2421-9. DOI: 10.1074/jbc.M308343200. View

13.

Johnson P, Betts K, Radeke M, Hageman G, Anderson D, JOHNSON L . Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc Natl Acad Sci U S A. 2006; 103(46):17456-61. PMC: 1859950. DOI: 10.1073/pnas.0606234103. View

14.

Barlow P, Steinkasserer A, Norman D, Kieffer B, Wiles A, Sim R . Solution structure of a pair of complement modules by nuclear magnetic resonance. J Mol Biol. 1993; 232(1):268-84. DOI: 10.1006/jmbi.1993.1381. View

15.

Hageman G, Anderson D, Johnson L, Hancox L, Taiber A, Hardisty L . A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A. 2005; 102(20):7227-32. PMC: 1088171. DOI: 10.1073/pnas.0501536102. View

16.

Sanchez-Corral P, Gonzalez-Rubio C, Rodriguez de Cordoba S, Lopez-Trascasa M . Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H. Mol Immunol. 2004; 41(1):81-4. DOI: 10.1016/j.molimm.2004.01.003. View

17.

Vaziri-Sani F, Holmberg L, Sjoholm A, Kristoffersson A, Manea M, Fremeaux-Bacchi V . Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome. Kidney Int. 2006; 69(6):981-8. DOI: 10.1038/sj.ki.5000155. View

18.

Sjoberg A, Onnerfjord P, Morgelin M, Heinegard D, Blom A . The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q. J Biol Chem. 2005; 280(37):32301-8. DOI: 10.1074/jbc.M504828200. View

19.

Sharma A, Pangburn M . Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proc Natl Acad Sci U S A. 1996; 93(20):10996-1001. PMC: 38272. DOI: 10.1073/pnas.93.20.10996. View

20.

Perkins S, Nealis A, Sim R . Oligomeric domain structure of human complement factor H by X-ray and neutron solution scattering. Biochemistry. 1991; 30(11):2847-57. DOI: 10.1021/bi00225a017. View